| Literature DB >> 35036429 |
JaeHo Yu1, Jeong-Hun Lim1, Sang-Woo Seo1, DongYeop Lee1, JiHeon Hong1, JinSeop Kim1, SeongGil Kim1, Daekook M Nekar1, HyeYun Kang1.
Abstract
Caffeine is considered a widely consumed natural and legal psychoactive stimulant with several effects on the body. The present study attempted to investigate the effects of caffeine consumed before and after a physical exercise on cardiovascular and cardiorespiratory functions in healthy adults. 36 healthy adult males were recruited and randomly allocated to one of the three (3) groups: group I (exercise without caffeine consumption), group II (caffeine beverage intake before exercise), and group III (caffeine beverage intake immediately after exercise). The heart rate (HR), QTc interval, blood pressure (BP), respiratory rate (RR), oxygen consumption (VO₂), and carbon dioxide emission (VCO₂) were measured at 0, 5, 10, and 15 min after the exercise. We observed a significant difference in all measured outcomes during the different recovery times in all the groups (p < 0.05). HR, RR, SBP, VO2, and VCO2 gradually decreased with time, DBP contrarily increased with time, and the QTc showed an irregular pattern. We can affirm that ingestion of caffeine before and after moderate aerobic exercise slows down the parasympathetic stimulation, heart rate recovery, and the recovery of HR and QTc with no major effects on BP, RR, VO₂, and VCO₂ in healthy adult men.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35036429 PMCID: PMC8754617 DOI: 10.1155/2022/3170947
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
General characteristics of participants.
| Gender | Male ( |
|---|---|
| Age | 24.7 ± 0.9 |
| Height (cm) | 178.8 ± 3.4 |
| Weight (kg) | 80.9 ± 10.7 |
Values are presented as mean ± standard deviation.
Figure 1CPX machine.
Figure 2The attached location of ECG: (a) anterior and (b) lateral side. (1) RA, (2) LA, (3) RL, (4) LL, (5) V1, (6) V2, (7) V3, (8) V4, (9) V5, and (10) V6.
Electrode placement.
| Electrode name | Electrode placement |
|---|---|
| RA | Place near the patient's right midclavicular line, directly below the clavicle |
| LA | Place near the patient's left midclavicular line, directly below the clavicle |
| RL | Place between the 6th and 7th intercostal space on the patient's right midclavicular line |
| LL | Place between the 6th and 7th intercostal space on the patient's left midclavicular line |
| V1 | In the fourth intercostal space just to the right of the sternum |
| V2 | In the fourth intercostal space just to the left of the sternum |
| V3 | Between leads V2 and V4 |
| V4 | In the fifth intercostal space in the midclavicular line |
| V5 | Horizontally even with V4, in the left anterior axillary line |
| V6 | Horizontally even with V4 and V5 in the midaxillary line |
Table adapted from Zoll R Series ALS Operator's Guide [22] and ECG & ECHO learning [23].
Figure 3Gas analyzer, blood pressure meter, and ECG on CPX.
Treadmill parameters.
| Stage | Time (mm:ss) | Speed (km/h) | Grade (%) |
|---|---|---|---|
| 1 | 01:00 | 5.0 | 0.0 |
| 2 | 02:00 | 8.0 | 0.0 |
| 3 | 02:00 | 9.0 | 0.0 |
| 4 | 02:00 | 10.0 | 0.0 |
| 5 | 02:00 | 11.0 | 0.0 |
Figure 4Research block diagram.
The change value of HR, RR, BP, VO2, VCO₂, and QTc in caffeine over time (N = 36).
| HR | RR | SBP | DBP | VO2 | VCO2 | QTc | ||
|---|---|---|---|---|---|---|---|---|
| I | 0 min | 170.08 ± 4.31 | 35.38 ± 6.24 | 180.25 ± 20.07 | 72.25 ± 13.65 | 3.29 ± 0.51 | 2.51 ± 0.35 | 368.00 ± 15.68a |
| 5 min | 100.25 ± 10.63a | 21.59 ± 2.71 | 149.42 ± 20.60 | 76.08 ± 13.35 | 0.64 ± 0.09a | 0.56 ± 0.12 | 408.08 ± 12.64a | |
| 10 min | 92.92 ± 8.29 | 19.09 ± 2.19 | 137.08 ± 14.61 | 83.67 ± 16.45 | 0.55 ± 0.07 | 0.38 ± 0.06 | 396.00 ± 17.57a | |
| 15 min | 88.00 ± 7.05a | 17.47 ± 2.83 | 130.67 ± 13.17 | 81.58 ± 12.17 | 0.50 ± 0.10 | 0.33 ± 0.07 | 386.17 ± 16.54a,b | |
|
| 714.898∗ | 71.189∗ | 53.178∗ | 3.806∗ | 408.393∗ | 542.635∗ | 28.850∗ | |
| II | 0 min | 172.50 ± 2.78 | 37.02 ± 6.46 | 194.00 ± 29.59 | 72.75 ± 17.64 | 3.62 ± 0.65 | 2.77 ± 0.54 | 391.75 ± 15.78a,c |
| 5 min | 110.83 ± 8.38a | 22.00 ± 3.05 | 154.42 ± 22.70 | 77.25 ± 12.77 | 0.81 ± 0.17a | 0.66 ± 0.16 | 421.83 ± 13.48a | |
| 10 min | 101.67 ± 8.38 | 20.41 ± 2.01 | 140.25 ± 11.00 | 85.42 ± 10.18 | 0.64 ± 0.11 | 0.42 ± 0.08 | 411.08 ± 13.56a | |
| 15 min | 97.50 ± 8.77a | 19.06 ± 1.71 | 137.33 ± 16.51 | 86.17 ± 10.35 | 0.58 ± 0.12 | 0.36 ± 0.07 | 405.42 ± 17.17a | |
|
| 676.194∗ | 103.288∗ | 32.770∗ | 3.838∗ | 332.713∗ | 284.947∗ | 19.370∗ | |
| III | 0 min | 168.43 ± 6.92 | 36.92 ± 6.48 | 185.75 ± 28.26 | 70.92 ± 17.40 | 3.39 ± 0.76 | 2.54 ± 0.61 | 370.33 ± 14.43c |
| 5 min | 103.00 ± 7.92 | 20.95 ± 2.98 | 152.67 ± 16.26 | 78.58 ± 7.77 | 0.73 ± 0.12 | 0.56 ± 0.09 | 408.42 ± 12.42 | |
| 10 min | 97.33 ± 8.78 | 19.03 ± 1.53 | 137.08 ± 14.45 | 86.67 ± 9.93 | 0.61 ± 0.06 | 0.41 ± 0.06 | 404.83 ± 10.32 | |
| 15 min | 94.67 ± 0.8.08 | 18.89 ± 2.74 | 133.75 ± 9.77 | 89.75 ± 8.42 | 0.58 ± 0.08 | 0.37 ± 0.06 | 405.58 ± 15.02a | |
|
| 656.448∗ | 79.231∗ | 35.935∗ | 8.763∗ | 183.377∗ | 159.974∗ | 32.186∗ | |
|
| 0 min | 2.044 | 0.250 | 0.830 | 0.040 | 0.846 | 0.929 | 8.766∗ |
| 5 min | 4.410∗ | 0.467 | 0.192 | 0.140 | 4.440∗ | 2.148 | 4.466∗ | |
| 10 min | 3.187 | 1.950 | 0.221 | 0.173 | 3.242 | 0.976 | 3.450∗ | |
| 15 min | 4.457∗ | 1.487 | 0.740 | 1.848 | 2.496 | 0.885 | 5.647∗ | |
I: exercise without caffeine; II: caffeine beverage intake before exercise; III: caffeine beverage intake immediately after exercise (∗p < 0.05, mean ± standard deviation); HR: heart rate; RR: respiratory rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; VCO2: oxygen consumption; VCO2: carbon dioxide emission; QTc: corrected QT interval. aDifference between I and II, bdifference between I and III, and cdifference between II and III.
Figure 5The change of HR, RR, BP, VCO2, VCO2, and QTc between groups over recovery time.